155 related articles for article (PubMed ID: 9636491)
1. Role of acute rejection in chronic rejection.
Vanrenterghem Y
Transplant Proc; 1998 Jun; 30(4):1210-1. PubMed ID: 9636491
[No Abstract] [Full Text] [Related]
2. Risk factors for acute rejection in 806 cyclosporine-treated renal transplants: a multivariate analysis.
Mota A; Figueiredo A; Cunha MF; Bastos M; Pratas J; Furtado L
Transplant Proc; 2003 May; 35(3):1061-3. PubMed ID: 12947856
[No Abstract] [Full Text] [Related]
3. The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.
Jirasiritham S; Sumethkul V; Mavichak V; Chalermsanyakorn P
Transplant Proc; 2000 Nov; 32(7):2040-2. PubMed ID: 11120057
[No Abstract] [Full Text] [Related]
4. Increasing incidence of steroid resistant rejection in kidney transplantation.
Arrazola L; Sozen H; Humar A; Papalois V; Uknis M; Matas AJ
Transplant Proc; 2000 Nov; 32(7):1767. PubMed ID: 11119926
[No Abstract] [Full Text] [Related]
5. Allograft instability with frequent acute rejections and early chronic transplant glomerulopathy related to suboptimal doses of cyclosporine A.
Savin M; Petronic V; Djukanovic L; Dujic A; Stojkovic D; Sindjic M
Transplant Proc; 1997 Nov; 29(7):2977-9. PubMed ID: 9365636
[No Abstract] [Full Text] [Related]
6. Acute rejection episodes predict long-term renal transplantation survival.
Kokado Y; Takahara S; Hatori M; Ichimaru I; Wang JD; Miki T; Okuyama A
Transplant Proc; 1997; 29(1-2):1537-40. PubMed ID: 9123416
[No Abstract] [Full Text] [Related]
7. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
[No Abstract] [Full Text] [Related]
8. Accelerated acute rejection in renal allograft.
Han DJ; Yoon HS; Lee HM
Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
[No Abstract] [Full Text] [Related]
9. Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases.
Morris-Stiff G; Singh J; Ostrowski K; Balaji V; Moore R; Darby C; Lord R; Jurewicz WA
Transplant Proc; 1998 Jun; 30(4):1295-6. PubMed ID: 9636525
[No Abstract] [Full Text] [Related]
10. A comparative analysis of methyl prednisone pulse versus orthoclone therapy in the management of acute cellular rejection.
Nampoory MR; Johny KV; Costandi JN; al-Muzairai IM; Gupta RK; Nair MP; Samhan M; al-Mousawi M
Transplant Proc; 1997 Nov; 29(7):2967-70. PubMed ID: 9365632
[No Abstract] [Full Text] [Related]
11. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
[No Abstract] [Full Text] [Related]
12. Twenty-six year surgical experience of 259 pediatric transplants in 235 children and long-term follow-up of 181 under cyclosporine therapy.
Berardinelli L; Ferraresso M; Raiteri M; Carini M; Vegeto A
Transplant Proc; 1998 Aug; 30(5):1977-9. PubMed ID: 9723359
[No Abstract] [Full Text] [Related]
13. Pediatric renal transplantation: personal experience.
Berloco P; Pretagostini R; Poli L; Rossi M; Iappelli M; Di Nicuolo A; Venettoni S; De Simone P; Cancrini C; Novelli G; Alfani D; Cortesini R; Lubrano R; Castello MA
Transplant Proc; 1996 Feb; 28(1):282-3. PubMed ID: 8644225
[No Abstract] [Full Text] [Related]
14. Risk factors for chronic graft dysfunction in 918 renal transplants.
Mota A; Figueiredo A; Macário F; Cunha FX; Freitas L; Parada B; Bastos C; Furtado L
Transplant Proc; 2003 May; 35(3):1064-5. PubMed ID: 12947857
[No Abstract] [Full Text] [Related]
15. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
Dudley CR;
Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
[No Abstract] [Full Text] [Related]
16. Early graft dysfunction developed within one week after renal allograft.
Kim SC; Jang HJ; Kim SK; Kim TH; Yoo ES; Jung JG; Han DJ
Transplant Proc; 2000 Nov; 32(7):1886-7. PubMed ID: 11119985
[No Abstract] [Full Text] [Related]
17. Kidney transplantation from living donors in Hungary: experience of 22 years.
Perner F; Hidvégi M; Járay J; Alföldy F; Gyódi E; Petrányi G
Transplant Proc; 1996 Dec; 28(6):3584-90. PubMed ID: 8962389
[No Abstract] [Full Text] [Related]
18. Chagas disease and transplantation.
Vazquez MC; Sabbatiello R; Schiavelli R; Maiolo E; Jacob N; Pattin M; Rearte A
Transplant Proc; 1996 Dec; 28(6):3301-3. PubMed ID: 8962281
[No Abstract] [Full Text] [Related]
19. Analysis of 160 consecutive living unrelated kidney transplants: 1983-1997.
Alfani D; Pretagostini R; Rossi M; Poli L; De Simone P; Colonnello M; Novelli G; Urbano D; Venettoni S; Persijn G; Smits J; Cortesini R
Transplant Proc; 1997 Dec; 29(8):3399-401. PubMed ID: 9414764
[No Abstract] [Full Text] [Related]
20. Cyclosporine-related hemolytic-uremic syndrome in kidney graft recipients: clinical and histomorphologic evaluation.
Bren AF; Kandus A; Buturovic J; Koselj M; Kaplan Pavlovcic S; Ponikvar R; Kovac D; Lindic J; Vizjak A; Ferluga D
Transplant Proc; 1998 Jun; 30(4):1201-3. PubMed ID: 9636487
[No Abstract] [Full Text] [Related]
[Next] [New Search]
